Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Lung Cancer. 2013 Mar 15;80(3):326–332. doi: 10.1016/j.lungcan.2013.02.011

Table 3.

Proportion of patients by subgroup that experienced declines to and recovery above given CrCl thresholds and the median time to these events A: CrCl threshold of 60 mL/min B: CrCl threshold of 45 mL/min

A.
Cohort Patients with
recorded
CrCl < 60
mL/min (%)		 Median time
to onset of
CrCl < 60
mL/min
(days)		 Patients
recovering to
CrCl ≥ 60
mL/min (%)* 		Median time to
recovery to CrCl
≥ 60 mL/min
(days)
All
patients 		23 83 66 27
Age
<65 17 92 56 21
≥65 40 2 78 36
Sex
Male 18 77 68 21
Female 29 94 65 31
Race
White 22 41 68 30
Afr-Amer 23 117 69 21
Hispanic 19 95 67 1
Asian 36 0 25 121
Race
White 18 41 68 30
Non-
white		 24 89 65 21
B.
Cohort Patients with
recorded
CrCl < 45
mL/min (%)		 Median time
to onset of
CrCl < 45
mL/min
(days)		 Patients
recovering to
CrCl ≥ 45
mL/min (%)* 		Median time to
recovery to
CrCl ≥ 45
mL/min (days)
All
patients 		11 122 61 36
Age
<65 18 108 67 6
≥65 19 232 53 72
Sex
Male 8 36 62 17
Female 16 260 60 57
Race
White 9 175 58 68
Afr-
Amer		 15 254 59 33
Hispanic 3 94 100 1
Asian 18 55 50 8
Race
White 9 175 58 68
Non-
white		 13 94 62 8
*

Of those patients who had recorded CrCl < 60 mL/min

*

Of those patients who had recorded CrCl < 45 mL/min